Opposite changes in serum soluble CD8 in patients at the active stages of Graves' and Hashimoto's diseases

Thyroid

Volumn 7, Issue 5, 1997, Pages 743-747

  Watanabe, Mikio ^a   Amino, Nobuyuki ^b   Hochito, Kazunori ^b   Watanabe, Kiyoshi ^b   Kuma, Kanji ^c   Iwatani, Yoshinori ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c KUMA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; THYROID HORMONE; THYROTROPIN RECEPTOR ANTIBODY;

ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME IMMUNOASSAY; GOITER; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; THYROID DISEASE; THYROID FUNCTION TEST;

EID: 0031431007     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1997.7.743     Document Type: Article

References (25)

1. Littmann DR 1987 The structure of the CD4 and CD8 genes. Ann Rev Immunol 5:561-584.
2. Ehlers MRW, Riordan JF 1991 Membrane proteins with soluble counterparts: Role of proteolysis in the release of transmembrane proteins. Biochemistry 30:10065-10074.
3. Imboden JB 1994 T lymphocytes and natural killer cells. In: Stites DP, Terr AI, Parslow TG (eds) Basic & Clinical Immunology. Appleton & Lange, East Norwalk, CT, pp. 94-104.
4. Fujimoto J, Levy S, Levy R 1983 Spontaneous release of the Leu-2 (T8) molecule from human T cells. J Exp Med 158:752-766.
5. Tomkinson BE, Brown MC, IP SH, Carrabis S, Sullivan JL 1989 Soluble CD8 during cell activation. J Immunol 142:2230-2236.
6. Symons JA, Wood NC, di GF, Duff GW 1990 Soluble CD8 in patients with rheumatic diseases. Clin exp Immunol 80:354-359.
7. Griffin DE, Ward BJ, Jauregui E, Jhonson RT, Vaisberg A 1989 Immune activation in measles. N Engl J Med 320:1667-1672.
8. Linker IM, Hyun S, Ozeri CT, Wallace DJ, Banks K, Klinenberg JR 1994 Elevated in vivo and in vitro secretion of CD8-α molecules in patients with systemic lupus erythematosus. J Immunol 152:3158-3167.
9. Cesare ED, Previti M, Ingemi MC, Bagnato GF, Cucinotta D 1994 High serum levels of soluble CD8 in insulin-dependent diabetes. Clin Exp Immunol 95:283-286.
10. Reddy MM, Lange M, Grieco MH 1989 Elevated soluble CD8 levels in sera of human immunodeficiency virus-infected populations. J Clin Microbiol 27:257-260.
11. Amino N 1986 Antithyroid antibodies. In: Ingbar SH, LE B (eds). Werner's The Thyroid J.B. Lippincott, Philadelphia, pp. 546-559.
12. Volpé R 1991 Graves' Disease - Pathogenesis. In: Braverman LE, Utiger RD (eds). The Thyroid. J.B. Lippincott Company, Philadelphia, pp. 648-657.
13. Volpé R 1991 Autoimmune Thyroiditis. In: Braverman LE, Utiger RD (eds) The Thyroid. J.B. Lippincott Company, Philadelphia, pp. 921-933.
14. Davies TF 1996 Graves' Disease - The pathogenesis of Graves' disease. In: Braverman LE, Utiger RD (eds). The Thyroid. J.B. Lippincott Company, Philadelphia, 525-536.
15. Weetman AP 1996 Chronic autoimmune thyroiditis. In: Braverman LE, Utiger RD (eds) The Thyroid. J.B. Lippincott Company, Philadelphia, 738-748.
16. + cells in active Hashimoto's disease and subacute thyroiditis. Clin Exp Immunol 87:444-449.
17. Balazs C, Bokk A, Farid NR 1994 Serum soluble CD8 concentration is an indicator of disease activity in patients with Graves' disease. Thyroid 4:27-30.
18. Murphy ED, Kallio P 1994 Soluble CD antigen (cytokine) expression in various hyperthyroid states and use in the assessment of propylthiouracil treatment. J Lab Clin Med 124:255-262.
19. + B cells in hyperthyroid Graves' disease. Clin Exp Immunol 78:196-200.
20. Olsson T, Bakhiet M, Hojeberg B, Ljungdahl A, Edlund C, Andersson G, Ekre HP, Fung LW, Mak T, Wigzell H, et al 1993 CD8 is critically involved in lymphocyte activation by a T. brucei brucei-released molecule. Cell 72:715-727.
21. Aoki N, Pinnamaneni KM, DeGroot LJ 1979 Studies on suppressor cell function in thyroid diseases. J Clin Endocrinol Metab 48:803-810.
22. Gerstein HC, Rastogi B, Iwatani Y, Iitaka M, Row W, Volpé R 1987 The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism. Clin Invest Med 10:337-344.
23. - cells, in autoimmune thyroid disease. Clin Exp Immunol 93:430-436.
24. MacKenzie WA, Davies TF 1987 An intrathyroidal T-cell clone specifically cytotoxic for human thyroid cells. Immunology 61:101-103.
25. MacKenzie WA, Schwartz AE, Friedman EW, F. DT 1987 Intrathyroidal T cell clones from patients with autoimmune thyroid disease. J Clin Endocrinol Metab 64:818-824.